# Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis

> **NCT02063399** · — · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 20302 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02063399
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-07
- **Primary completion:** 2016-08
- **Final completion:** 2023-06
- **Target enrollment:** 20302 (ACTUAL)
- **Last updated:** 2022-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02063399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02063399, "Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02063399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*